مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: Triple therapy: worth the risk?
Normal view MARC view ISBD view

Triple therapy: worth the risk? [electronic resource]

By:
  • Wernly, Bernhard
Contributor(s):
  • Lichtenauer, Michael
  • Hoppe, Uta C
  • Lauten, Alexander
  • Navarese, Eliano P
  • Jung, Christian
Producer: 20181106Description: 403-405 p. digitalISSN:
  • 1827-1669
Subject(s):
  • Anticoagulants -- administration & dosage
  • Aspirin -- administration & dosage
  • Clopidogrel
  • Drug Synergism
  • Drug Therapy, Combination -- adverse effects
  • Factor Xa Inhibitors -- administration & dosage
  • Hemorrhage -- chemically induced
  • Humans
  • Mortality
  • Multicenter Studies as Topic
  • Myocardial Infarction -- etiology
  • Platelet Aggregation Inhibitors -- administration & dosage
  • Postoperative Complications -- prevention & control
  • Purinergic P2Y Receptor Antagonists -- administration & dosage
  • Randomized Controlled Trials as Topic
  • Rivaroxaban -- administration & dosage
  • Stents
  • Stroke -- prevention & control
  • Thrombophilia -- drug therapy
  • Ticlopidine -- administration & dosage
Online resources:
  • Available from publisher's website
In: Minerva medica vol. 109
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article; Meta-Analysis

There are no comments on this title.

Log in to your account to post a comment.

Triple therapy: worth the risk?

APA

Wernly B., Lichtenauer M., Hoppe U. C., Lauten A., Navarese E. P. & Jung C. (20181106). Triple therapy: worth the risk?. : Minerva medica.

Chicago

Wernly Bernhard, Lichtenauer Michael, Hoppe Uta C, Lauten Alexander, Navarese Eliano P and Jung Christian. 20181106. Triple therapy: worth the risk?. : Minerva medica.

Harvard

Wernly B., Lichtenauer M., Hoppe U. C., Lauten A., Navarese E. P. and Jung C. (20181106). Triple therapy: worth the risk?. : Minerva medica.

MLA

Wernly Bernhard, Lichtenauer Michael, Hoppe Uta C, Lauten Alexander, Navarese Eliano P and Jung Christian. Triple therapy: worth the risk?. : Minerva medica. 20181106.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site